retatrutide efficacy clinical trials Today, we shared new data from two Phase 3 of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide 2026: Everything Confirmed So

Figure 2A illustrates the dose-effect curves, and their respective D m values were calculated as 4.21, 3.20, 0.78, and 3.42 g/mL (Table 1)

Pharmacists Perspective Faryal Faisal, PharmD One question I get constantly is should I skip a dose escalation to avoid side effects? The answer is firmly no but you can ask your prescriber to delay an escalation by 24 weeks if you are still adapting

"Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates

Contact your GP or NHS 111 for persistent or worsening dizziness, signs of dehydration, frequent hypoglycaemia, or true vertigo with spinning sensations